Table 3. N mening conjugate C, A and A + C vaccine studies.
Reference | Authors | Year Published | Vaccine | Population | Country | Study Design |
---|---|---|---|---|---|---|
149 | Fairley, Begg, Borrow et al. | 1996 | Men A and C-CRM197 | Infants | UK | S and I |
82 | Leach, Twumasi, Kumah et al. | 1997 | Men A + C-CRM197 | Children | The Gambia | Immune Memory |
83 | MacDonald, Halperin, Law et al. | 1998 | Men C-CRM197 | Toddlers | Canada | Immune Memory |
84 | Richmond, Borrow, Miller et al. | 1999 | Men C-CRM197 | Infants | UK | S and I |
85 | MacLennan, Shackley, Heath et al. | 2000 | Men C-CRM | Infants | UK | S and I and Immune Memory |
150 | Campagne, Garba, Fabre et al. | 2000 | Men A + C-D | Infants | Niger | S and I |
153 | Zhang, Lakshman, Burkinshaw et al. | 2001 | Men A + C-CRM197 | Adolescents/Adults | UK | Mucosal I |
86 | Richmond, Borrow, Goldblatt et al. | 2001 | Men C – T/CRM197 | Toddlers | UK | Immune Memory |
87 | MacLennen, Obaro, Deeks et al. | 2001 | Men A + C-CRM197 | Children | The Gambia | Immune Memory |
151 | Miller, Salisbury, Ramsay et al. | 2001 | Men C – T/CRM197 | Children/Adults | UK | Effectiveness |
152 | Ramsay, Andrews, Kaczmarski et al. | 2001 | Men C – T/CRM197 | Toddlers/Adolescents | UK | Effectiveness |
154 | Rennels, Edwards, Keyserling et al. | 2001 | Men C-CRM197 | Infants | USA | S and I |
88 | Borrow, Goldblatt, Andrews et al. | 2002 | Men C-CRM197 | Children | UK | Immune Memory |
89 | McVernon, MacLennan, Buttery et al. | 2002 | Men C-CRM197 | Infants/Children | UK | S and I |
155 | Joseph, Ryall and Bybel et al. | 2003 | Men A + C-D | Children | UK | I + Immune Memory |
135 | De Wals, Deceuninck, Boulianne et al. | 2004 | Men C-CRM197 | Infants to Adults | Canada | Effectiveness |
136 | Trotter, Andrews, Kaczmrski et al. | 2004 | Men C – T/CRM197 | Infants to Adolescents | UK | Effectiveness |
156 | De Wals, Deceuninck, De Serres et al. | 2005 | Men C-CRM197 | Children/Adolescents | Canada | Effectiveness |
157 | Gray, Trotter, Ramsay et al. | 2006 | Men C – T/CRM197 | Children/Adolescents | UK | Effectiveness |
158 | de Greeff, de Melker, Spanjaard et al. | 2006 | Men C-T | Toddlers | Netherlands | Effectiveness |
159 | Snape, Kelly, Salt et al. | 2006 | Men C-CRM197 | Adolescents | UK | Immune Memory |
160 | Trotter, Chandra, Cano et al. | 2007 | Men C – T/CRM197 | Children/Adolescents | Europe | Effectiveness |
161 | Kshirsagar, Mur, Thatte et al. | 2007 | Men A-T | Adults | India | S and I |
162 | Maiden, Ibarz-Pavon, Urwin et al. | 2008 | Men C – T/CRM197 | Adolescents | UK | Efficacy on NP carriage |
163 | Bettinger, Scheifele, Le Saux et al. | 2009 | Men C-CRM197 | Infants to Adults | Canada | Effectiveness |
164 | De Wals, Deceuninck, Lefebvre et al. | 2011 | Men C-CRM197 | Infants to Adults | Canada | Effectiveness |
S, Safety; I, Immunogenicity; E, Efficacy.